Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (1041-1050 of 1,157) with videos related to

Pageof 116
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neurobiology of Aging|June 18, 2019
Lifespan normative data on rates of brain volume changesMarco Battaglini, Giordano Gentile, Ludovico Luchetti, et al.
Neuroimage. Clinical|April 21, 2021
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated referencesAlexandra de Sitter, Jessica Burggraaff, Fabian Bartel, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 116

Showing results (1041-1050 of 1,157) with videos related to

Sort By:
Pageof 116
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Neurology|June 17, 2016
Assessing response to interferon-β in a multicenter dataset of patients with MSMaria Pia Sormani, Claudio Gasperini, Marzia Romeo, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextMaria Pia Sormani, Irene Schiavetti, Luca Carmisciano, et al.
Genes|October 23, 2021
An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis PatientsNadia Barizzone, Rachele Cagliani, Chiara Basagni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2022
Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 yearsEmilio Portaccio, Luisa Pastò, Lorenzo Razzolini, et al.
Neurobiology of Aging|June 18, 2019
Lifespan normative data on rates of brain volume changesMarco Battaglini, Giordano Gentile, Ludovico Luchetti, et al.
Neuroimage. Clinical|April 21, 2021
Development and evaluation of a manual segmentation protocol for deep grey matter in multiple sclerosis: Towards accelerated semi-automated referencesAlexandra de Sitter, Jessica Burggraaff, Fabian Bartel, et al.
Journal of Clinical Medicine|March 29, 2023
Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and DepressionCristiano Scandurra, Laura Rosa, Antonio Carotenuto, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 116